Specs, Family & Sourcing

Flat lay of medical syringes and glass ampules arranged on a white background.

retatrutide

Retatrutide Per-mg Cost vs Tirzepatide and Semaglutide

How retatrutide's per-mg cost compares to tirzepatide and semaglutide, and why listed vial prices alone rarely tell the full per-mg pricing story.

Medically reviewed by Thomas Kline, PhD, biochemist — Last reviewed

Thomas Kline, PhD is a biochemist with a doctorate in structural biochemistry from MIT and 16 years of research in GLP receptor biology and synthetic peptide analog pharmacology.

Comparing how retatrutide’s per-mg cost stacks up against tirzepatide and semaglutide requires more than reading three listed prices side by side. Vial size, molecular weight, and reconstitution volume all change what a buyer is actually paying for once the number is reduced to a common unit. This article walks through the math that turns a sticker price into a per-mg figure, and explains why that figure moves depending on how a vial is prepared.

Why raw vial price is a poor comparison point

Suppliers list peptides in vials sized differently across compounds and even across the same compound from different sources. A 5 mg vial and a 10 mg vial of the same peptide are not twice as different in value just because the number on the label doubled, and vials are not directly comparable on sticker price alone either. Retatrutide listings commonly appear in 5 mg, 10 mg, and higher vial sizes, tirzepatide listings follow a similar pattern, and semaglutide is frequently listed in smaller vial sizes given its lower typical concentration in commercial peptide catalogues. The only way to compare them meaningfully is to divide total vial price by total mg content, producing a per-mg figure for each.

The per-mg calculation

The formula is straightforward:

Per-mg price = total vial price ÷ mg of peptide in the vial

This calculation is independent of how the vial is later reconstituted. Reconstitution changes concentration (mg per mL), not the total mg of peptide purchased, so it plays no part in a per-mg cost comparison; it only affects how that peptide is measured out afterward.

Worked example

Suppose a listing shows a 10 mg retatrutide vial priced at $220, a 10 mg tirzepatide vial priced at $150, and a 5 mg semaglutide vial priced at $90. The per-mg figures work out as follows:

  • Retatrutide: $220 ÷ 10 mg = $22.00 per mg
  • Tirzepatide: $150 ÷ 10 mg = $15.00 per mg
  • Semaglutide: $90 ÷ 5 mg = $18.00 per mg
CompoundVial sizeListed pricePer-mg cost
Retatrutide10 mg$220$22.00
Tirzepatide10 mg$150$15.00
Semaglutide5 mg$90$18.00

In this example, retatrutide’s per-mg cost comes out highest of the three, tirzepatide the lowest, and semaglutide in between. These are illustrative figures for demonstrating the arithmetic, not a claim about any specific supplier’s current catalogue. Actual listed prices vary by source and change over time, so the calculation itself is the transferable part, not the dollar amounts above.

Why retatrutide often lists at a higher per-mg figure

Retatrutide is a larger, more complex molecule than semaglutide, and its synthesis involves more amino acid residues than either semaglutide or tirzepatide. Peptide synthesis cost tends to scale with sequence length and structural complexity, which is one of the factors that can push per-mg pricing higher for larger molecules regardless of vial size. This is a structural explanation for why prices differ, not a statement about which compound performs better for any purpose; cost and molecular size are related but describe different things entirely.

Reconstitution volume does not change per-mg cost, but it changes measured concentration

A common point of confusion is treating reconstitution as though it affects the price paid per mg. It does not. Adding bacteriostatic water to a vial changes the concentration (mg per mL), which in turn changes how many units on a U-100 insulin syringe correspond to a given mg amount. It does not change the total mg purchased or the total price paid.

For example, a 10 mg vial reconstituted with 2 mL of bacteriostatic water yields a concentration of 5 mg/mL (10 mg ÷ 2 mL = 5 mg/mL). The same 10 mg vial reconstituted with 5 mL yields 2 mg/mL (10 mg ÷ 5 mL = 2 mg/mL). Either way, the buyer paid for 10 mg of peptide at whatever the vial’s listed price was; reconstitution only changes how that 10 mg is distributed across syringe volume, not what it cost.

Reading listings side by side

When comparing listings across retatrutide, tirzepatide, and semaglutide, a few variables are worth checking before drawing conclusions from price alone:

  1. Total mg in the vial is the denominator in the per-mg calculation.
  2. Listed price is the numerator, and the only figure that should include any shipping or bundling adjustments if those are part of the comparison.
  3. Purity or concentration claims on the certificate of analysis, where available, describe what is actually in the vial rather than what the label states.

Catalogues that carry multiple compounds side by side, such as the listing for retatrutide, make this kind of comparison easier because vial sizes and pricing structures are presented in a consistent format rather than scattered across different supplier pages with different conventions.

Why per-mg cost is only one variable

Per-mg cost describes the price of the raw material. It does not describe purity, third-party testing practices, storage and shipping conditions, or how a given listing’s stated concentration was verified. Two vials with identical per-mg pricing can differ substantially in these other respects, which is why per-mg cost functions best as one comparison point among several rather than the sole basis for evaluating a listing.

For readers building out a broader picture of where retatrutide sits relative to other compounds in the same research category, the categorized overview at Reta Info covers additional comparison angles, and the calculator-oriented breakdowns at Reta Online walk through related reconstitution figures in more detail.

Summary

Comparing retatrutide, tirzepatide, and semaglutide by per-mg cost means dividing each listing’s total price by its total mg content, not comparing sticker prices directly, and setting aside reconstitution volume, which affects concentration rather than cost. Retatrutide often lists at a higher per-mg figure than tirzepatide, reflecting its larger molecular structure, while semaglutide’s per-mg cost tends to fall between the two depending on vial size and source. Reading listings with total mg, listed price, and available purity documentation side by side gives a clearer basis for comparison than any single number in isolation.

← All articles